Alan J. Russell, Chief Scientific Officer at Edgewise Therapeutics, Inc. (EWTX), sold 479 shares at $19.07 ($9K) on 2021-11-15, disclosed to the SEC on 2021-11-17.
Scheduled sale ($9k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.07 | 441 | $8K | 91.9% |
| 2 | $19.61 | 38 | $745 | 8.1% |
| Total | $19.11 avg | 479 | $9K | 100% |
| Filing → |
| EWTX | SELL | 2025-11-13 | $2.1M | — | Filing → |
| EWTX | SELL | 2025-08-28 | $1.5M | — | Filing → |
| EWTX | SELL | 2025-08-14 | $26K | — | Filing → |